Grade My Investments
Home › Free Stock Grades › RXST

RxSight, Inc. (RXST) Stock Grade

RXST · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$193.3M
P/E Ratio
—
Revenue Growth (YoY)
-3.9%
Net Margin
-29.0%
Return on Equity
—
Dividend Yield
None

About RxSight, Inc.'s fundamentals

RxSight, Inc. is a small-cap medical device company with a market capitalization of $193.3 million that reported a net loss in its latest annual statement, resulting in a negative net margin of -29.0%. The company experienced a revenue decline of 3.9% year-over-year, indicating contraction in sales. With no dividend yield and profitability metrics unavailable, the company is currently in a loss-making position as it operates in the competitive medical devices sector.

Track RXST free — no credit card required. Live grade + monthly AI report →